AR059357A1 - Formulaciones farmaceuticas - Google Patents
Formulaciones farmaceuticasInfo
- Publication number
- AR059357A1 AR059357A1 ARP070100512A ARP070100512A AR059357A1 AR 059357 A1 AR059357 A1 AR 059357A1 AR P070100512 A ARP070100512 A AR P070100512A AR P070100512 A ARP070100512 A AR P070100512A AR 059357 A1 AR059357 A1 AR 059357A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical formulations
- pleconaril
- solution
- hydrofluorocarbon
- dissolves
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Un medicamento que incluye una solucion que contiene pleconaril o una sal farmacéuticamente aceptable del mismo, en donde al menos un solvente que incluye la solucion es un hidrofluorcarbono que disuelve pleconaril.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77192106P | 2006-02-09 | 2006-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059357A1 true AR059357A1 (es) | 2008-03-26 |
Family
ID=38283182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100512A AR059357A1 (es) | 2006-02-09 | 2007-02-07 | Formulaciones farmaceuticas |
Country Status (9)
Country | Link |
---|---|
US (2) | US20070203104A1 (es) |
EP (1) | EP1981545A2 (es) |
JP (1) | JP2009526062A (es) |
AR (1) | AR059357A1 (es) |
CA (1) | CA2641616A1 (es) |
MX (1) | MX2008010353A (es) |
PE (1) | PE20071231A1 (es) |
TW (1) | TW200806291A (es) |
WO (1) | WO2007095039A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004020289A1 (en) * | 2002-08-27 | 2004-03-11 | Schering Corporation | Process for producing metered dose inhaler formulations |
MX2008010350A (es) * | 2006-02-09 | 2008-10-31 | Schering Corp | Formulaciones farmaceuticas. |
US20080253970A1 (en) * | 2007-02-09 | 2008-10-16 | Schering Corporation | Stable Pharmaceutical Drug Products |
TW201016215A (en) * | 2008-07-17 | 2010-05-01 | Schering Corp | Compositions and uses of antiviral active pharmaceutical agents |
CN102552116B (zh) * | 2010-12-24 | 2015-07-22 | 无锡济民可信山禾药业股份有限公司 | 一种呋麻滴鼻液的制备方法 |
GB201113662D0 (en) * | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
WO2014031964A1 (en) * | 2012-08-24 | 2014-02-27 | Vr1, Inc. | Composition for the treatment of migraine headaches |
US20160193188A1 (en) * | 2013-08-15 | 2016-07-07 | Antivirus Therapeutics | Methods and compositions for increasing the effectiveness of antiviral agents |
WO2015070181A1 (en) * | 2013-11-08 | 2015-05-14 | Anitvirus Therapeutics | Methods and compositions for treating sepsis |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE179605T1 (de) * | 1991-02-09 | 1999-05-15 | B S D Bio Science Dev Snc Di O | Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation |
CZ271393A3 (en) * | 1991-06-10 | 1994-07-13 | Schering Corp | Aerosol preparations without chlorofluorinated hydrocarbons |
HUT67449A (en) * | 1991-06-10 | 1995-04-28 | Schering Corp | Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane |
US5175177A (en) * | 1991-07-17 | 1992-12-29 | Sterling Drug Inc. | 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
US5349068A (en) * | 1992-04-15 | 1994-09-20 | Sterling Winthrop Inc. | 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
US5453433A (en) * | 1994-05-13 | 1995-09-26 | Sterling Winthrop Inc. | Thiadiazoles and antipicornaviral compositions |
US6068832A (en) * | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
US6565832B1 (en) * | 2000-01-31 | 2003-05-20 | Schering-Plough Healthcare Products, Inc. | Spray composition with reduced dripping |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
US20050027127A1 (en) * | 2001-08-29 | 2005-02-03 | Diana Guy D. | Oxadiazolyl-phenoxyalkylisoxazoles compositions thereof and methods for their use as anti-picornaviral agents |
WO2003020271A1 (en) * | 2001-08-29 | 2003-03-13 | Viropharma Incorporated | Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
CA2464250C (en) * | 2001-10-24 | 2008-08-05 | Frank-Christophe Lintz | Kit for the preparation of a pharmaceutical composition |
US20060167109A1 (en) * | 2002-02-14 | 2006-07-27 | Pevear Daniel C | Methods of reducing rhinovirus contagion and related compositions |
CA2495689A1 (en) * | 2002-08-23 | 2004-03-04 | Schering Corporation | Pharmaceutical compositions |
MXPA06004331A (es) * | 2003-10-20 | 2006-06-05 | Schering Corp | Composiciones farmaceuticas. |
MX2007001561A (es) * | 2004-08-04 | 2007-04-16 | Schering Corp | Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas. |
MX2008010350A (es) * | 2006-02-09 | 2008-10-31 | Schering Corp | Formulaciones farmaceuticas. |
-
2007
- 2007-02-07 EP EP07717220A patent/EP1981545A2/en not_active Withdrawn
- 2007-02-07 MX MX2008010353A patent/MX2008010353A/es not_active Application Discontinuation
- 2007-02-07 WO PCT/US2007/003306 patent/WO2007095039A2/en active Application Filing
- 2007-02-07 US US11/672,400 patent/US20070203104A1/en not_active Abandoned
- 2007-02-07 JP JP2008554321A patent/JP2009526062A/ja active Pending
- 2007-02-07 AR ARP070100512A patent/AR059357A1/es not_active Application Discontinuation
- 2007-02-07 CA CA002641616A patent/CA2641616A1/en not_active Abandoned
- 2007-02-08 TW TW096104530A patent/TW200806291A/zh unknown
- 2007-02-08 PE PE2007000137A patent/PE20071231A1/es not_active Application Discontinuation
-
2010
- 2010-02-17 US US12/707,424 patent/US20100144610A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2641616A1 (en) | 2007-08-23 |
EP1981545A2 (en) | 2008-10-22 |
WO2007095039A2 (en) | 2007-08-23 |
US20070203104A1 (en) | 2007-08-30 |
US20100144610A1 (en) | 2010-06-10 |
TW200806291A (en) | 2008-02-01 |
MX2008010353A (es) | 2009-03-05 |
JP2009526062A (ja) | 2009-07-16 |
WO2007095039A3 (en) | 2008-05-08 |
PE20071231A1 (es) | 2008-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR059357A1 (es) | Formulaciones farmaceuticas | |
AR059359A1 (es) | Formulaciones farmaceuticas que contienen pleconaril | |
CO6511251A2 (es) | Compuestos quimicos | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
GT200500246A (es) | Combinacion de compuestos organicos | |
UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
UY30759A1 (es) | Compuestos quimicos | |
ES2421613T3 (es) | Composición farmacéutica externa | |
DOP2006000170A (es) | Nuevos derivados de espirocromanona | |
CL2007003686A1 (es) | Compuestos derivados de indol con anillo unido en las posiciones 4,5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar una infeccion viral. | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
ES2422557T3 (es) | Compuestos y composiciones como moduladores de la ruta Hedgehog | |
ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
CL2012002944A1 (es) | Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
CL2012002945A1 (es) | Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
UY31215A1 (es) | Compuestos de morfolino pirimidina, procesos para su preparacion, composiciones farmacéuticas conteniéndolos y su uso en terapia. | |
BRPI0606339A2 (pt) | formas farmacêuticas resistentes a álcool | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
CR20120296A (es) | Nuevos compuestos de espiropiperidina | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
DE502007005902D1 (de) | -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate | |
UY32424A (es) | Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |